Precision Medicine: PSMA Targeted Therapies in Progressive Metastatic Prostate Cancer Videos

Effectiveness of PSMA-Lutetium for Prostate Cancer Liver Metastases - Daniel Childs

Online Platform Maps Theranostic Trials Worldwide for Patients and Physicians - Luke Nordquist

Copper-67 (Cu-67 or 67Cu) in Cancer Therapy: Current Developments and Future Potential - Alan Taylor

COBRA Trial: Evaluating 64Cu-SAR-bisPSMA PET Imaging for Prostate Cancer Detection - Phillip Koo

Highlights: UCLA/UCSF Inaugural PSMA PET and RLT Conference - Jeremie Calais

Nuclear Medicine Physician Discusses Career Path and Field Growth - Louise Emmett

ENZA-p Trial Explores Enzalutamide-Lutetium Combination in Prostate Cancer - Louise Emmett

The Evolution of PSMA Theranostics: A 30-Year Journey with the Prostate Cancer Foundation - Andrea Miyahira

A Historical Perspective on Radioligand Therapy and Novel Treatment Modalities in the Management of mCRPC - Neil H. Bander

PSMA PET Imaging Hot Topics - Neal Shore & Jason Efstathiou

Imaging and PET Analysis as a Prognostic Tool for Lu-PSMA-617 Treatment in Patients with mCRPC - Phillip H. Kuo

Clinical Trial Equity in Radionuclide Treatment for Prostate Cancer - Joseph Osborne

Clinical Implementation of Pluvicto™ (177Lu-PSMA-617) - Michael Morris

Pluvicto™ (177Lu-PSMA-617) Indications for Clinical Use in PSMA Positive Metastatic Castration-Resistant Prostate Cancer mCRPC - Oliver Sartor

Pluvicto The First Targeted Radioligand Therapy for Treatment of Metastatic Castration-Resistant Prostate Cancer FDA Approved - Charles Ryan and Alicia Morgans

Radiopharmaceuticals in Prostate Cancer: A Deep Dive into Patient-Reported Outcomes - Scott Tagawa

The Upfront PSMA Study: Shifting Paradigms in Metastatic Hormone-Sensitive Disease - Declan Murphy & Arun Azad

Lutetium-177 PSMA: A Closer Look at Its Therapeutic Potential and Side Effects - Bennett Chin

Academic and Community Practice Perspectives on Integrating PSMA Lutetium in the Clinic: Lessons Learned from Radium-223 Experience - Oliver Sartor and Nicholas Vogelzang

Precision Medicine: RadioIsotopes Targeted Therapies in Cancer - Stefano Fanti

Radionuclide Targeted Treatment in Progressing Metastatic Prostate Cancer - Michael Hofman

PSMA Targeted Radiopharmaceuticals in Prostate Cancer: Pivotal Phase III VISION Trial - Oliver Sartor

PSMA-PET Imaging in Prostate Cancer & PSMA as a Therapeutic Target in Prostate Cancers - Thomas Hope and Johannas Czernin

PSMA-directed Therapy - Scott Tagawa and Michael Morris

Radiation Safety with Targeted Radionuclide Therapy - Thomas Hope